“I Just Knew That I Needed Help”: Primarily Latine Adolescents and Young Adults Speak About Medication Treatment for Opioid Use Disorder in the Fentanyl Era
- 29 September 2026
- journal article
- Published by SAGE Publications in Substance use & addiction journal
Abstract
Background: Medications for opioid use disorder (MOUD) are evidence-based, lifesaving treatments for adolescents and young adults (AYAs) with opioid use disorder (OUD). However, AYAs access MOUD at alarmingly low rates. Therefore, this study investigated facilitators, barriers, and health services preferences for accessing MOUD among AYAs desiring treatment for OUD within a safety-net health system. Methods: We conducted 11 semi-structured interviews with AYAs aged 16 to 21 who initiated MOUD in a county safety-net health system. Patients started MOUD (primarily buprenorphine) in inpatient, outpatient, and/or emergency department settings. We employed combined inductive and deductive coding and thematic analysis. Results: Ten of 11 (91%) AYAs identified as Latine, and 9 (82%) were publicly insured. We identified 4 themes: (1) AYAs weighed the consequences of ongoing non-prescribed opioid use when deciding to engage in treatment; (2) perceived therapeutic and adverse effects of MOUD influenced AYAs’ desire to start and continue MOUD; (3) Relationships with peers, caregivers, parole officers, and healthcare providers enabled AYAs to start and continue OUD treatment; (4) Inpatient MOUD initiation experiences were largely positive, though a few had negative experiences. Conclusion: This predominantly publicly insured, Latine sample of AYAs with OUD identified relationships, perceived risks of opioids, and perceived effectiveness of MOUD as key facilitators to engage in MOUD. Also, AYAs largely appreciated starting MOUD inpatient, though many identified barriers to continuing MOUD long-term. These perspectives provide essential input into future research, clinical, and public health interventions.Keywords
Funding Information
- Stanford University
- Stanford University’s Pediatrics Residency Community Investment Grant
- National Center for Advancing Translational Sciences (K12TR00493)
- Pediatric Scientist Development Program (1K23HD113841-01A1)
This publication has 23 references indexed in Scilit:
- Medications for Opioid Use Disorder for Youth: Patient, Caregiver, and Clinician PerspectivesJournal of Adolescent Health, 2023
- Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults’ PerspectivesJournal of Adolescent Health, 2022
- Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021JAMA, 2022
- Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young AdultsJAMA Pediatrics, 2022
- Medication for Adolescents and Young Adults With Opioid Use DisorderJournal of Adolescent Health, 2021
- Opioid Use Disorder Treatment Facilities With Programs for Special PopulationsAmerican Journal of Preventive Medicine, 2020
- Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use DisorderJAMA Pediatrics, 2018
- Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014JAMA Pediatrics, 2017
- Explaining Racial/Ethnic Differences in Adolescent Substance Abuse Treatment Completion in the United States: A Decomposition AnalysisJournal of Adolescent Health, 2014
- Assertive Outreach Strategies for Narrowing the Adolescent Substance Abuse Treatment Gap: Implications for Research, Practice, and PolicyThe Journal of Behavioral Health Services & Research, 2008